156 related articles for article (PubMed ID: 10825560)
1. Oral sustained delivery of theophylline using in-situ gelation of sodium alginate.
Miyazaki S; Kubo W; Attwood D
J Control Release; 2000 Jul; 67(2-3):275-80. PubMed ID: 10825560
[TBL] [Abstract][Full Text] [Related]
2. Oral sustained delivery of theophylline from thermally reversible xyloglucan gels in rabbits.
Miyazaki S; Kawasaki N; Endo K; Attwood D
J Pharm Pharmacol; 2001 Sep; 53(9):1185-91. PubMed ID: 11578100
[TBL] [Abstract][Full Text] [Related]
3. In situ-gelling gellan formulations as vehicles for oral drug delivery.
Miyazaki S; Aoyama H; Kawasaki N; Kubo W; Attwood D
J Control Release; 1999 Aug; 60(2-3):287-95. PubMed ID: 10425334
[TBL] [Abstract][Full Text] [Related]
4. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
[TBL] [Abstract][Full Text] [Related]
5. Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations.
Kubo W; Miyazaki S; Attwood D
Int J Pharm; 2003 Jun; 258(1-2):55-64. PubMed ID: 12753753
[TBL] [Abstract][Full Text] [Related]
6. Oral sustained delivery of ambroxol from in situ-gelling pectin formulations.
Kubo W; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
Int J Pharm; 2004 Mar; 271(1-2):233-40. PubMed ID: 15129990
[TBL] [Abstract][Full Text] [Related]
7. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
[TBL] [Abstract][Full Text] [Related]
8. Excipient-excipient interaction in the design of sustained-release theophylline tablets: in vitro and in vivo evaluation.
Bayomi MA; Al-Suwayeh SA; El-Helw AR
Drug Dev Ind Pharm; 2001 Jul; 27(6):499-506. PubMed ID: 11548856
[TBL] [Abstract][Full Text] [Related]
9. Oral sustained delivery of theophylline and cimetidine from in situ gelling pectin formulations in rabbits.
Kubo W; Itoh K; Miyazaki S; Attwood D
Drug Dev Ind Pharm; 2005 Sep; 31(8):819-25. PubMed ID: 16221617
[TBL] [Abstract][Full Text] [Related]
10. Design and characterization of calcium-free in-situ gel formulation based on sodium alginate and chitosan.
Belhadji L; HadjSadok A; Moulai-Mostefa N
Drug Dev Ind Pharm; 2018 Apr; 44(4):662-669. PubMed ID: 29172753
[TBL] [Abstract][Full Text] [Related]
11. In situ cross-linking of sodium alginate with calcium and aluminum ions to sustain the release of theophylline from polymeric matrices.
Nokhodchi A; Tailor A
Farmaco; 2004 Dec; 59(12):999-1004. PubMed ID: 15598436
[TBL] [Abstract][Full Text] [Related]
12. Relative bioavailability and bioequivalence study of theophylline sustained release formulations.
Vergin H; Mahr G; Winterhalter B; Wigand R
Arzneimittelforschung; 2003; 53(9):635-9. PubMed ID: 14558437
[TBL] [Abstract][Full Text] [Related]
13. Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan.
El Maghraby GM; Elzayat EM; Alanazi FK
Drug Dev Ind Pharm; 2012 Aug; 38(8):971-8. PubMed ID: 22092113
[TBL] [Abstract][Full Text] [Related]
14. In situ gelling pectin formulations for oral sustained delivery of paracetamol.
Kubo W; Konno Y; Miyazaki S; Attwood D
Drug Dev Ind Pharm; 2004 Jul; 30(6):593-9. PubMed ID: 15285332
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
16. In situ gelling xyloglucan/pectin formulations for oral sustained drug delivery.
Itoh K; Yahaba M; Takahashi A; Tsuruya R; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
Int J Pharm; 2008 May; 356(1-2):95-101. PubMed ID: 18295417
[TBL] [Abstract][Full Text] [Related]
17. The influence of gastric acidity and taste masking agent on in situ gelling pectin formulations for oral sustained delivery of acetaminophen.
Itoh K; Kubo W; Fujiwara M; Watanabe H; Miyazaki S; Attwood D
Biol Pharm Bull; 2006 Feb; 29(2):343-7. PubMed ID: 16462043
[TBL] [Abstract][Full Text] [Related]
18. Zinc-pectinate beads as an in vivo self-assembling system for pulsatile drug delivery.
Dhalleine C; Assifaoui A; Moulari B; Pellequer Y; Cayot P; Lamprecht A; Chambin O
Int J Pharm; 2011 Jul; 414(1-2):28-34. PubMed ID: 21601627
[TBL] [Abstract][Full Text] [Related]
19. [Sustained-release effect of the direct compressed tablet based on chitosan and Na alginate].
Yomota C; Miyazaki T; Okada S
Yakugaku Zasshi; 1994 Apr; 114(4):257-63. PubMed ID: 8201547
[TBL] [Abstract][Full Text] [Related]
20. In-situ fast gelling formulation for oral sustained drug delivery of paracetamol to dysphagic patients.
Sharma S; Sarkar G; Srestha B; Chattopadhyay D; Bhowmik M
Int J Biol Macromol; 2019 Aug; 134():864-868. PubMed ID: 31102679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
